What happened, in summary

Susan had continued annual breast examinations and mammograms because of dense breasts. A July mammogram was read as normal, but in October she felt a new lump in her left breast. A repeat 3-D mammogram, ultrasound, and biopsy found invasive ductal carcinoma. The cancer was 100% estrogen-receptor positive and HER2-negative. Her surgeon described it as Stage I, possibly Stage II, with lymph nodes appearing unremarkable on ultrasound and MRI.

Susan pushed to complete a bilateral breast MRI before meeting the surgeon so that the treatment discussion would include as much information as possible. She then underwent breast surgery to remove the known tumor. Final pathology was still needed to clarify the stage and recurrence risk. Radiation was expected if the risk was low, while chemotherapy would be considered if pathology showed higher risk; long-term estrogen-blocking therapy was also anticipated. A 74-gene blood panel was sent for hereditary-risk assessment.

While waiting for the next decisions, Susan used nutrition counseling, exercise, visualization, and counseling to manage fear and regain a sense of control. She also became more direct about breast awareness, encouraging women to learn what is normal for their own bodies and to seek further evaluation when something changes, even after recent reassuring imaging.